Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Castle Biosciences Inc have a median target of 41.00, with a high estimate of 50.00 and a low estimate of 36.00. The median estimate represents a 41.97% increase from the last price of 28.88.
High | 73.1% | 50.00 |
Med | 42.0% | 41.00 |
Low | 24.7% | 36.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | -0.89% |
Average growth rate | -94.45% |
More ▼
Revenue history & estimates in USD
Average growth rate | +8.93% |
Average growth rate | +44.25% |
More ▼